Home › T19 Categories › * Culture-Watch › (BBC) Gene therapy: Glybera approved by European Commission
T19 Access
Search
Categories Main
Categories Exhaustive
T19 Resources
T19 Access
Search
Categories Main
Categories Exhaustive
T19 Resources
(BBC) Gene therapy: Glybera approved by European Commission
A treatment which corrects errors in a person’s genetic code has been approved for commercial use in Europe for the first time.
The European Commission has given Glybera marketing authorisation, meaning it can be sold throughout the EU.
It is a gene therapy for a rare disease which leaves people unable to properly digest fats.
Read it all.